- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0026736

About Pentavalent Bio Sciences Private Limited
Data last updated:
Pentavalent Bio Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85110KA2015PTC078991. Its GSTIN is 29AAICP0183G1ZB (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹18.05 Lakh. It is led by directors Soumya Paul and Murali Shripathy Harishchandra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹17.25 Lakh (net margin 8.6%) and EBITDA of ₹25.84 Lakh (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years and 49% over five years.
The company is associated with 1 brand: Pentavalent. As per MCA filings, the company has open charges of ₹2 Cr on record.
Pentavalent Bio Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0026736). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pentavalent.in.
Company details
Recognitions & Rankings of Pentavalent Bio Sciences
Contact details
Pentavalent Bio Sciences Private Limited's registered office is in Bangalore, Karnataka. Its website is pentavalent.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 202 1st Floor Kssidc Block – 1, Electronic City Phase – 1 Hosur Road, Bangalore, Karnataka, India – 560100
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pentavalent Bio Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Pentavalent Bio Sciences operates one associated brand: Pentavalent. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Vaccines and research services for infectious diseases are provided. | pentavalent.in |
Financials of Pentavalent Bio Sciences Private Limited
FY 2024 filings availablePentavalent Bio Sciences Private Limited reported revenue of ₹2.01 Cr (up 356% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 356% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.01 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | 8.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pentavalent Bio Sciences Private Limited, buy the company report.
Board of directors of Pentavalent Bio Sciences Private Limited
Pentavalent Bio Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Soumya Paul | Director | 24 Feb 2015 | 11 Years 8 Months | Current |
| Murali Shripathy Harishchandra | Director | 04 Dec 2015 | 10 Years 11 Months | Current |
Auditor
Pentavalent Bio Sciences Private Limited is audited by NARAYAN BHAT & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NARAYAN BHAT & CO | FY 2023 | 05011S |
Shareholding
The shareholding of Pentavalent Bio Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pentavalent Bio Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Dec 2023 | 100872078 | Sidbi | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Pentavalent Bio Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Pentavalent Bio Sciences Private Limited has 3 MSME Form 1 returns on record for the period ending Mar 2019, listing 15 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Pentavalent Bio Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Pentavalent Bio Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICP0183G1ZB | Karnataka | Active | 15 Jul 2020 |
To see the full GST registrations and return filing status of Pentavalent Bio Sciences Private Limited, buy the company report.
Recent activity
Pentavalent Bio Sciences Private Limited has 8 board changes on record since 2015: 5 appointments and 3 cessations. The latest: Bhavani Venkataswamachari Peddayelachagiri ceased to be Director on 01 Aug 2020.
Frequently asked questions
Pentavalent Bio Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 February 2015 (11+ years old) and is registered under CIN U85110KA2015PTC078991.
Pentavalent Bio Sciences has 2 current directors:
- Soumya Paul - Director
- Murali Shripathy Harishchandra - Director
The latest financial statements of Pentavalent Bio Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Pentavalent Bio Sciences is 29AAICP0183G1ZB, registered in Karnataka.
The CIN (Corporate Identification Number) of Pentavalent Bio Sciences is U85110KA2015PTC078991. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pentavalent Bio Sciences was incorporated on 24 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
Bhavani Venkataswamachari Peddayelachagiri ceased to be Director on 01 Aug 2020. Raghavendra Maddur Puttaswamy ceased to be Director on 01 Aug 2020. Raghavendra Maddur Puttaswamy was appointed as Director on 03 May 2016. Pentavalent Bio Sciences has 8 board changes on record in total.
Yes, Pentavalent Bio Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0026736).
Pentavalent Bio Sciences has 3 MSME Form 1 returns on record for the period ending Mar 2019, listing 15 overdue payments to 1 micro and small supplier. The latest return was filed on 10 Jun 2019.
Pentavalent Bio Sciences can be reached through the website pentavalent.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Pentavalent Bio Sciences is at B – 202 1st Floor Kssidc Block – 1, Electronic City Phase – 1 Hosur Road, Bangalore, Karnataka, India – 560100.

